|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1983-8-11
|
|
pubmed:abstractText |
Three doses of inactivated hepatitis B vaccine were given at 1-month intervals to 31 hepatitis B surface antigen (HBsAg)-positive Senegalese children aged between 3 and 24 months. A control group of 18 HBsAg-positive Senegalese children received diphtheria-tetanus-polio vaccine. Immunization of HBsAg-positive infants with hepatitis B vaccine was safe but inefficient. After a 12-month follow-up, the prevalence of HBsAg chronic carriers was not significantly reduced in the hepatitis B vaccine group as compared with the control group: 48.4 and 66.7%, respectively. The presence of hepatitis B antigen was found to be a major risk factor for HBsAg-positive children to develop a chronic carrier state. The risk of developing an HBsAg chronic carrier state was also related to advancing age at time of enrollment in the study.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-441677,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-59012,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6109938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6110088,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6111671,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6118576,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6120276,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6267609,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6281640,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-681144,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6972051,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-6997738,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-7073149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-718020,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-7232758,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6222991-7232760
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
83-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:6222991-Carrier State,
pubmed-meshheading:6222991-Child, Preschool,
pubmed-meshheading:6222991-Hepatitis B,
pubmed-meshheading:6222991-Hepatitis B Antibodies,
pubmed-meshheading:6222991-Hepatitis B Surface Antigens,
pubmed-meshheading:6222991-Hepatitis B Vaccines,
pubmed-meshheading:6222991-Hepatitis B e Antigens,
pubmed-meshheading:6222991-Humans,
pubmed-meshheading:6222991-Infant,
pubmed-meshheading:6222991-Vaccination,
pubmed-meshheading:6222991-Viral Vaccines
|
|
pubmed:year |
1983
|
|
pubmed:articleTitle |
Hepatitis B vaccine: further studies in children with previously acquired hepatitis B surface antigenemia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
